Literature DB >> 34536774

Neuromyelitis optica spectrum disorder (NMOSD) associated with cancer: A systematic review.

Sareh Shahmohammadi1, Rozita Doosti1, Abootorab Shahmohammadi1, Amirreza Azimi1, Mohammad Ali Sahraian1, Mohammad-Reza Fattahi1, Abdorreza Naser Moghadasi2.   

Abstract

NMOSD: is a disease shown to be highly associated with other diseases such as autoimmune diseases. There are a few reports of this association with cancer. So, this systematic review aimed to obtain a broad understanding on the cancers associated in NMOSD, including the source of common perceptions and assumptions in this regard.
METHODS: in this study, we systematically searched the PubMed, EMBASE, SCOPUS, Web of Sciences, Proquest, Ovid, conference proceedings, and reference lists of the retrieved articles. All NMOSD cases who met the last version of criteria for its diagnosis, which reported the patients with a history of cancer before or after the onset of neurological symptoms without time limitations, and those who were referred as paraneoplastic neuromyelitis optica in articles published in English language (both the abstract & full text), were assessed. Finally, each study was critically appraised.
RESULTS: Only 47 studies met the inclusion criteria, so they were assessed for qualitative synthesis. Considering the Euro network criteria, only 62 cases met this issue. The mean age of 52.21 ± 17.14 and 52.16 ± 17.21 was reported for cancer and NMOSD cases with female predominance (79%), respectively. The most reported organ in the cancer population were genitourinary (n = 14, 22.3%), breast (n = 12, 19.4%), lung (n = 12, 19.3%), gastrointestinal (n = 7, 11.3%), and hematology (n = 6, 9.7%), respectively.
CONCLUSION: In older NMOSD patients without suspicious symptoms, we recommend paying more attention to lung, breast and genitourinary (especially ovary) cancer screening. Also, cancer resection had positive effect on the attack numbers after receiving treatment and NMOSD recovery.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Malignancy; NMOSD; Paraneoplastic syndrome

Mesh:

Substances:

Year:  2021        PMID: 34536774     DOI: 10.1016/j.msard.2021.103227

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  3 in total

1.  Aquaporin-4-Positive Triple-Negative Breast Cancer Presenting with Paraneoplastic Neuromyelitis Optica Spectrum Disorder.

Authors:  Pilar Carrillo; Teresa Gorría; Daniel Santana; Maria Sepulveda; Iban Aldecoa; Blanca Gonzalez-Farré; Esther Sanfeliu; Eduard Mension; Isaac Cebrecos; Olga Martínez-Saez; Imma Alonso; Albert Saiz
Journal:  Biomed Hub       Date:  2022-01-31

2.  NMOSD-Diagnostic Dilemmas Leading towards Final Diagnosis.

Authors:  Anna K Szewczyk; Ewa Papuć; Krystyna Mitosek-Szewczyk; Michał Woś; Konrad Rejdak
Journal:  Brain Sci       Date:  2022-07-06

3.  Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated With Lung Adenocarcinoma: A Case Report.

Authors:  Carlo Maiorca; Federica Moret; Valentina Martines; Daniele Tramontano; Maria Alessia Papassifachis; Simone Bini; Claudia Caramazza; Mario Fontana; Piernatale Lucia; Maurizio Inghilleri
Journal:  Front Med (Lausanne)       Date:  2022-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.